FMO5 and chronic granulomatous disease: For the diagnosis of CGD, reactive oxygen intermediates (O2− or H2O2) generated by the NADPH oxidase in phagocytes of peripheral blood are measured upon in vitro activation with either PMA and/ or TLR4 ligands (E. coli or LPS).